Read about the Top 100 AD Researchers
Home Alzheimer 100 Advertising
About JAD Alzheimer Award Recommend JAD
Editorial Board Press Releases Feedback
For Authors Subscriptions Search
Contents/Abstracts Related Links Letters to Editor

  JOURNAL OF ALZHEIMER'S DISEASE

an IOS Press publication

FOR AUTHORS

Submission Checklist

F O R   A U T H O R S

SYNOPSIS

Editorial Policy and Review Process
Editorial Board
Roles of the Associate and Senior Editors

SUBMISSION DETAILS

Submission Letter and Method of Transmission
Manuscript Preparation
Disclosure Statement
Submission Checklist
Publication Fee/Open Access
Copyright
Proofs
 

POLICIES

Overview of Policies on Manuscript Submission
Policy regarding the NIH Public Access Policy mandate (PubMed Central)
Policy on the Use of  Animals
Policy on the Use of  Human Subjects
Policy on Ethics
Financial Disclosure
Information for Reviewers

REPRINTS

Offprints and Reprints 

REMEMBER TO INCLUDE

In cover letter:

  Name, postal address, phone number, fax number and e-mail address of the corresponding author.

  Name of an Associate Editor with expertise in the area of the study (if no Associate Editor is suitable, the Editorial Office will handle the submission).

  Statement that all authors have contributed to the work, agree with the presented findings, and that the work has not been published before nor is being considered for publication in another journal.

  A list of at least 4-6 potential reviewers knowledgeable in the area of the study and potential reviewer conflicts.

  Statement that procedures involving experiments on human subjects are done in accord with the ethical standards of the Committee on Human Experimentation of the institution in which the experiments were done or in accord with the Helsinki Declaration of 1975.

  Statement that procedures involving experimentation on animal subjects are done in accord with either the guide of the institution in which the experiments were done, or with the National Research Council's guide for the care and use of laboratory animals.

  Statement of all financial and material support for this research and any potential conflicts.

In manuscript:

 Compliance with guidelines on human experimentation as well as protocol approval by a local Institutional Review Board should be specified.

 Compliance with guidelines of animal experimentation as well as protocol approval by the Institutional Animal Care and Use Committee should be specified.

 Statement of all financial and material support for this research and any potential conflicts should also be clearly identified in the acknowledgement section.

 Nomenclature for amyloids should follow the 1999 guidelines of the International Nomenclature Committee on Amyloidosis (Amyloid: Int J Exp Clin Invest 6, 63-66, 1999), e.g., amyloid β (Aβ) and amyloid β-protein precursor (AβPP).

 Manuscripts should be typed on one side of the paper only, with wide margins and double spacing throughout, including the abstract and references. Every page of the manuscript, including the title page, references, tables, etc., should be numbered in the upper right-hand corner.

 Manuscripts must have an abstract (250 words or less) and 4-10 keywords.

 References should be cited in order of appearance with numbers between square brackets. All publications cited in the text should be presented in order of appearance in a list of references following the text of the manuscript.

top


http://www.worldpharmacongress.com/alz

The Journal of Alzheimer's Disease is published by IOS Press. ©1998-2008 Journal of Alzheimer's Disease